维普中文期刊产品整合服务
26篇 您的检索式:作者名="MONTASTRUC JL"
    题名 作者 年代 出处 被引量
1Adverse drug reactions and off-label drug use in pediatric patients 显示文摘HOREN B MONTASTRUC JL LAPEYRE-MESTREM 2002Br J Clin Pharmacol2002,54,6:1
2Pioglitazone and bladder cancer显示文摘Hillaire-Buys D Faillie JL Montastruc JL 2011Lancet2011,378,9802:1
3Pharmacological and clinical evidences on the potential for abuse and dependence of propo- fol: a review of the literature显示文摘Roussin A Montastruc JL Lapeyre - Mestre M 2007Fundam Clin Pharmacol2007,21,5:1
4Arandomized,doubleblind study of a skin patch of a dopaminergic agonist,piribedil,in Parkinson's disease显示文摘Montastruc JL Ziegler M Rasco LO 1999Mov Disord1999,14,:1
5Adverse drug re-actions and off-label drug use in paediatric outpatients显示文摘Horen B Montastruc JL Lapeyre-Mestre M 2002Br JClin Pharmacol2002,54,6:1
6Adverse drug reactions related to drugs used in orthostatic hypotension:a prospective and systematic pharmacovigilance study in France显示文摘Pathak A Raoul V Montastruc JL 2005Eur J Clin Pharmacol2005,61,56:1
7Pharmacovigilance for evaluating adverse drug reactions: value,organization, and methods 显示文摘Montastruc JL Sommet A Lacroix I 2006Joint Bone Spine2006,73,6:1
8Abnormal ocular move- ments in Parkinson's disease: evidence for involvement of dopamin- ergic mechanisms显示文摘Rascol O Clanet M Montastruc JL 1989Brain1989,112,5:1
9Abnormal ocular movements in Parkinson's disease : evidence for involvement of dopaminergic mechanisms显示文摘Rascol O Clanet M Montastruc JL 1989Brain1989,112,5:1
10Levodopa montherapy can indue 'sleep attacks' in Parkinson's disease patients显示文摘Ferreia JJ Thalamas C Montastruc JL 2001J Neurol2001,248,5:1
11显示文摘Montastruc JL Llau ME Rascol O 1994Fundam Clin Pharmacol1994,8,4:1
12Adverse drug reaction and off-label drugs use in pediatric outpatients显示文摘Horen B Montastruc JL Lapeyre-Mestre M 2002Br J Clin Pharmacol2002,54,6:1
13Benefits and strengths of the disproportionality analysis for identification of adverse drug re- actions in a pharmacovigilance database 显示文摘Montastruc JL Sommet A Bagheri H 2011BJCP2011,72,6:1
14Pharmacological and clini- cal evidences on the potential for abuse and dependence of propofol:a review of the literature显示文摘Anne R JL Montastruc Maryse LM 2007Fundamental & Clinical Pharnaeology2007,21,:1
15Pharmacological prospects for α2-adrenoceptor antagonist therapy显示文摘Berlan M Montastruc JL Lafontan M 1992Trends Pharmacol Sci1992,13,7:1
16Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations: a randomized, double-blind, multicentre study显示文摘Fenelon G Gimenez Roldan S Montastruc JL 2003Neural Transm2003,110,:1
17Adverse drug reactions to anthelmintics显示文摘Bagheri H Simiand E Montastruc JL 2004Ann Pharmacother2004,38,3:1
18Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database显示文摘Olivier-Abbal P Teisseyre AC Montastruc JL 2013Med Oncol2013,30,4:1
19Effect of lysine-vasopressin and oxytocin on central cardiovascular control 显示文摘Trand LD Montastruc JL 1982Br J Phamacol1982,77,1:1
20Photosensitivity to Ketopro- fen: mechanisms and pharmacuepidemiological data显示文摘Bagheri H Lhiaubet V Montastruc JL 2000Drug Safety2000,22,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费